Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. GlaxoWellcome Production
FDA Inspection
•GlaxoWellcome Production•March 3, 2017

FDA Inspection 1005796 - GlaxoWellcome Production - March 03, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns GlaxoWellcome Production, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
GlaxoWellcome Production
Inspection Date
March 3, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Open in Dashboard

ID · b673f0a0-aaff-450b-b76a-74f9a1411f35

Violation Codes1
21 CFR 314.81(b)(1)(ii)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.